Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • [RFA] Use of PD Biosamples - Spring 2020, 2024
    Neurotoxic Inflammatory Metabolites as Biomarkers of Disease Progression in Parkinson’s Disease

    Study Rationale: Individuals with Parkinson’s disease (PD) have inflammation in the brain, cerebrospinal fluid and the blood. We think that inflammation drives the worsening of PD because it increases...

  • Research Grant, 2024
    Chronos-PD Pilot: Analyzing Plasma from Donors Who Develop Parkinson’s Disease Later in Life

    Study Rationale: Our current molecular understanding of Parkinson’s disease (PD) is based on the clinical phase of the disease. However, because PD is a progressive disease, by the time the disorder...

  • Parkinson’s Disease Therapeutics Pipeline Program, 2024
    Preclinical Development of a Novel Therapeutic for Parkinson’s Disease

    Study Rationale: Inflammation in the brain (neuroinflammation) is a key feature of Parkinson’s disease (PD), and signaling molecules called prostaglandins play a pivotal role in controlling chronic...

  • Research Grant, 2024
    (SUPPLEMENT) Cataloguing Proteomic Differences in LRRK2-Associated Parkinsonism With and Without Evidence of Pathologic Neuronal Alpha-synuclein

    Study Rationale: Alpha-synuclein is a protein found throughout the brain and body. In most people with Parkinson’s disease (PD), an accumulation of abnormal alpha-synuclein is thought to contribute to...

  • Biomarkers to Support Therapeutic Trials Program, 2024
    Using Detection of Apoptosing Retinal Cells to Predict Disease Activity in Parkinson’s Disease

    Study Rationale: In preclinical models, detection of apoptosing retinal cells (DARC) allows identification of cells in the eye that are under stress and at risk of damage from Parkinson’s disease (PD)...

  • Research Grant, 2024
    Developing A Resource for Exploring the Molecular Markers of Parkinson’s Disease

    Study Rationale: Our understanding of the genetic, immunological and molecular determinants of Parkinson’s disease (PD) has advanced significantly over the past decade. Using this extensive body of...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.